Curcumin + Piperine

by Herbadiet · powder · N/A

  • On the market (NIH)
  • DSLD label 244249
  • Serving 400 to 800 mg; amounts per 400 mg

Curcumin + Piperine by Herbadiet lists 2 ingredients, 2 with an amount per serving of 400 mg, such as 385 mg of curcumin extract powder and 15 mg of piperine extract powder. Its current label entered the NIH Dietary Supplement Label Database on March 25, 2021.

What is in Curcumin + Piperine?

Each row as the label prints it, per serving of 400 mg. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Curcumin + Piperine: Supplement Facts rows against the market (DSLD label 244249, January 2026 release)
IngredientAmount% DVAmong products listing it
Curcumin extract powderas Bis-Desmethoxy Curcumin, Curcuminoids-Curcumin, Desmethoxy CurcuminCurcumin extract powder (Form: standardized to contain minimum 95% Curcuminoids-Curcumin, Bis-Desmethoxy Curcumin, Desmethoxy Curcumin)385 mgCurcumin in Curcumin + Piperine against 550 products385 mg per serving; the middle half of products list 50 mg to 400 mg, the median 200 mg.385 mg

Higher than 72% of 550 products listing curcumin (median 200 mg).

Piperine extract powderas PiperinePiperine extract powder (Form: standardized to contain minimum 95% Piperine)15 mgPiperine in Curcumin + Piperine against 203 products15 mg per serving; the middle half of products list 4.75 mg to 10 mg, the median 5 mg.15 mg

Higher than 86% of 203 products listing piperine (median 5 mg).

Source: NIH ODS Dietary Supplement Label Database, label 244249 (entered March 25, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

3 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: As a dietary supplement, take up to 800mg daily, or as directed by physician.
Warnings
Keep out of reach of children.
Warning: Pregnant or lactating women should consult your physician before use.
Allergens and what it does not contain
Free of fillers, binders, artificial ingredients, dairy, soy, wheat, gluten, yeast
Storage
Store in a dry, cool & dark.

Source: label statements in DSLD label 244249.

How many labels does Curcumin + Piperine have?

One label is on file, entered on March 25, 2021.

  1. Label 244249 (current) Entered March 25, 2021 · on the market · N/A

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Arkure Health Care (distributor), Rohtak, Haryana, India. All Herbadiet products.

Where next?